These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 11948540)

  • 1. Bioavailability and efficacy of antisense morpholino oligomers targeted to c-myc and cytochrome P-450 3A2 following oral administration in rats.
    Arora V; Knapp DC; Reddy MT; Weller DD; Iversen PL
    J Pharm Sci; 2002 Apr; 91(4):1009-18. PubMed ID: 11948540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. c-Myc antisense limits rat liver regeneration and indicates role for c-Myc in regulating cytochrome P-450 3A activity.
    Arora V; Knapp DC; Smith BL; Statdfield ML; Stein DA; Reddy MT; Weller DD; Iversen PL
    J Pharmacol Exp Ther; 2000 Mar; 292(3):921-8. PubMed ID: 10688605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the rat cytochrome P450 3A2 by an antisense phosphorothioate oligodeoxynucleotide in vivo.
    Desjardins JP; Iversen PL
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1608-13. PubMed ID: 8531135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorodiamidate morpholino antisense oligomers inhibit expression of human cytochrome P450 3A4 and alter selected drug metabolism.
    Arora V; Cate ML; Ghosh C; Iversen PL
    Drug Metab Dispos; 2002 Jul; 30(7):757-62. PubMed ID: 12065433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transdermal use of phosphorodiamidate morpholino oligomer AVI-4472 inhibits cytochrome P450 3A2 activity in male rats.
    Arora V; Hannah TL; Iversen PL; Brand RM
    Pharm Res; 2002 Oct; 19(10):1465-70. PubMed ID: 12425463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction in tamoxifen-induced CYP3A2 expression and DNA adducts using antisense technology.
    Mahadevan B; Arora V; Schild LJ; Keshava C; Cate ML; Iversen PL; Poirier MC; Weston A; Pereira C; Baird WM
    Mol Carcinog; 2006 Feb; 45(2):118-25. PubMed ID: 16329150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antisense oligonucleotides targeted to the p53 gene modulate liver regeneration in vivo.
    Arora V; Iversen PL
    Drug Metab Dispos; 2000 Feb; 28(2):131-8. PubMed ID: 10640509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transdermal delivery of antisense oligonucleotides can induce changes in gene expression in vivo.
    Brand RM; Hannah TL; Norris J; Iversen PL
    Antisense Nucleic Acid Drug Dev; 2001 Feb; 11(1):1-6. PubMed ID: 11258617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-2 overexpresses c-myc and down-regulates cytochrome P-450 in rat hepatocytes.
    Tinel M; Elkahwaji J; Robin MA; Fardel N; Descatoire V; Haouzi D; Berson A; Pessayre D
    J Pharmacol Exp Ther; 1999 May; 289(2):649-55. PubMed ID: 10215635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-MYC antisense phosphosphorodiamidate morpholino oligomer inhibits lung metastasis in a murine tumor model.
    Sekhon HS; London CA; Sekhon M; Iversen PL; Devi GR
    Lung Cancer; 2008 Jun; 60(3):347-54. PubMed ID: 18096271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo bioavailability and pharmacokinetics of a c-MYC antisense phosphorodiamidate morpholino oligomer, AVI-4126, in solid tumors.
    Devi GR; Beer TM; Corless CL; Arora V; Weller DL; Iversen PL
    Clin Cancer Res; 2005 May; 11(10):3930-8. PubMed ID: 15897595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex-differentiated deoxycholic acid promotion of rat liver carcinogenesis is under pituitary control.
    Porsch Hällström I; Svensson D; Blanck A
    Carcinogenesis; 1991 Nov; 12(11):2035-40. PubMed ID: 1934288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone regulation of male-specific rat liver P450s 2A2 and 3A2: induction by intermittent growth hormone pulses in male but not female rats rendered growth hormone deficient by neonatal monosodium glutamate.
    Waxman DJ; Ram PA; Pampori NA; Shapiro BH
    Mol Pharmacol; 1995 Nov; 48(5):790-7. PubMed ID: 7476908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance to chemotherapeutic drugs overcome by c-Myc inhibition in a Lewis lung carcinoma murine model.
    Knapp DC; Mata JE; Reddy MT; Devi GR; Iversen PL
    Anticancer Drugs; 2003 Jan; 14(1):39-47. PubMed ID: 12544257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Manipulation of metallothionein expression in the regenerating rat liver using antisense oligonucleotides.
    Arora V; Iversen PL; Ebadi M
    Biochem Biophys Res Commun; 1998 May; 246(3):711-8. PubMed ID: 9618277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of human chorionic gonadotropin beta-subunit modulates the mitogenic effect of c-myc in human prostate cancer cells.
    Devi GR; Oldenkamp JR; London CA; Iversen PL
    Prostate; 2002 Nov; 53(3):200-10. PubMed ID: 12386920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formation of 8-hydroxydeoxyguanosine and cell-cycle arrest in the rat liver via generation of oxidative stress by phenobarbital: association with expression profiles of p21(WAF1/Cip1), cyclin D1 and Ogg1.
    Kinoshita A; Wanibuchi H; Imaoka S; Ogawa M; Masuda C; Morimura K; Funae Y; Fukushima S
    Carcinogenesis; 2002 Feb; 23(2):341-9. PubMed ID: 11872643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) modulates rat liver microsomal cyclophosphamide and ifosphamide activation by suppressing cytochrome P450 2C11 messenger RNA levels.
    Chang TK; Chen H; Waxman DJ
    Drug Metab Dispos; 1994; 22(5):673-9. PubMed ID: 7835216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of antisense morpholino oligomer targeted to c-myc in prostate cancer xenograft murine model and a Phase I safety study in humans.
    Iversen PL; Arora V; Acker AJ; Mason DH; Devi GR
    Clin Cancer Res; 2003 Jul; 9(7):2510-9. PubMed ID: 12855625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of vitamin A deficiency on the expression of low affinity glucocorticoid binding site activity and glucocorticoid-dependent induction of CYP3A2 in rat liver.
    Wright MC; Allenby G; Paine AJ
    Biochem Biophys Res Commun; 1997 Aug; 237(2):211-6. PubMed ID: 9268688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.